CANADIAN SUPERIOR ENERGY, Inc. (SNG) – Business Wire
-
Altius Provides 1st Quarter 2023 Project Generation Update
-
Synairgen announces positive data from the US NIH-led ACTIV-2 Phase 2 trial for SNG001 in home-based participants with COVID-19
-
Synairgen to Present 60 and 90-day Long COVID Data From Phase 3 SPRINTER Study in Hospitalised COVID-19 Patients at IDWeek 2022
-
Synairgen announces positive findings from analysis of lung samples from the SG015 trial of SNG001 in virally infected COPD patients
-
Synairgen Presents Detailed Analysis of Phase 3 SPRINTER Trial Evaluating SNG001 in Hospitalised COVID-19 Patients at ATS 2022
-
Akron Biotech Signs Agreement With Synairgen plc to Supply Interferon-beta for COVID-19 Treatment
Back to SNG Stock Lookup
